SearchDictionaryMobileLogin

Rolandic Epilepsy (Centrotemporal Epilepsy)

Subscribe to Selected New Research on Rolandic Epilepsy
29  relevant articles (0 outcomes, 4 trials/studies) found for this Disease

Description: An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and dysarthria. The episodes tend to occur at night and may become secondarily generalized. In most cases, affected children are neurologically and developmentally normal. The electroencephalogram shows characteristic high-voltage sharp waves over the central temporal regions, which are more prominent during drowsiness and sleep. In general, seizures do not continue beyond mid-adolescence. (From Epilepsia 1998 39;Suppl 4:S32-S41)

Also Known As:
Centrotemporal Epilepsy; Epilepsy, Rolandic; BCECTS; Benign Epilepsy, Childhood, Centrotemporal Spikes; Benign Rolandic Epilepsy; Centralopathic Epilepsy; Benign Childhood Epilepsy With Centro Temporal Spikes; Centralopathic Epilepsies; Centrotemporal Epilepsies; Epilepsies, Centralopathic; Epilepsies, Centrotemporal; Epilepsies, Rolandic; Epilepsy, Benign Rolandic; Epilepsy, Centralopathic; Epilepsy, Rolands; Epilepsy, Sylvian; Rolandic Epilepsies; Rolandic Epilepsy, Benign; Benign Childhood Epilepsy With Centro-Temporal Spikes; Benign Rolandic Epilepsy of Childhood; Epilepsy, Centrotemporal; Rolands Epilepsy; Sylvian Epilepsy

Disease Context: Research Results

-
Nervous System Diseases: 3424
-
Central Nervous System Diseases: 931
-
Brain Diseases: 1121
-
Epilepsy: 13930
-
Partial Epilepsies: 1108
*
Rolandic Epilepsy: 29

Related Diseases

1. Epilepsy (Aura)
2. Absence Epilepsy (Absence Seizure)
3. Seizures (Seizure)
4. Myoclonus (Nocturnal Myoclonus)
5. Generalized Epilepsy

Experts

1. Seri, Stefano: 2 articles (07/2004 - 01/2004)
2. Kossoff, Eric H: 1 article (12/2007)
3. Los, Jenna G: 1 article (12/2007)
4. Boatman, Dana F: 1 article (12/2007)
5. Korean Pediatric Topiramate Study Group: 1 article (09/2007)
6. Kim, Joon-Sik: 1 article (09/2007)
7. Lim, Kyunghwa: 1 article (09/2007)
8. Ku Moon, Han: 1 article (09/2007)
9. Wu Lee, Chang: 1 article (09/2007)
10. Young Chae, Kyu: 1 article (09/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Rolandic Epilepsy:
1. Silver Sulfadiazine (SSD)FDA LinkGeneric
2. Penicillins (Penicillin)FDA Link
3. Glucose (Dextrose)FDA LinkGeneric
4. zaleplon (Sonata)FDA Link
5. Carbamazepine (Tegretol)FDA LinkGeneric
6. Anticonvulsants (Antiepileptic Drugs)IBA
7. Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
8. Immunoglobulin E (IgE)IBA
9. topiramate (Topamax)FDA Link
10. lamotrigine (Lamictal)FDA LinkGeneric

Therapies and Procedures

1. High-Frequency Ventilation

Best Treatments:
Research Summary Report
on Rolandic Epilepsy
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 0 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>